Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death
Molecules · 24.03.2025 · 30 (7) · 1445
DOI: 10.3390/molecules30071445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 24.03.2025. Verfasst von Marcus de Bourg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, N-0316 Oslo, Norway. Hauptthemen laut MEDLINE: Sorafenib, Mesangial Cells, 8,11,14-Eicosatrienoic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences, NIEHS Superfund Research Program.
Abstract (Originalsprache)
Nineteen potential mimics of 8,9-epoxyeicosatrienoic acid (8,9-EET), a natural bioactive oxylipin, were synthesized and evaluated for their ability to protect renal mesangial cells against sorafenib-induced cell death in a water-soluble tetrazolium (WST-8) assay. All compounds were also evaluated as inhibitors of soluble epoxide hydrolase. As expected of a potent pan-kinase inhibitor the drug sorafenib caused a significant decrease in cell viability in HRMCs. Several analogs containing amide and oxamide groups in place of the epoxide showed efficacy in reducing sorafenib induced human renal mesangial cell (HRMC) death. Oxamide containing analogs proved particularly effective, with the most promising analog increasing cell viability five-fold over control at 1 µM. These analogs, containing an oxamide group as a bioisostere for the epoxide in 8,9-EET, did not display significant inhibitory activity towards soluble epoxide hydrolase. This preliminary structure–activity relationship analysis reveals the oxamide group as a promising bioisostere for the epoxide in the 8,9-position of the fatty acid chain, producing protective effects against sorafenib-induced cell death in HRMCs. Collectively, these findings demonstrate the potential for using epoxide mimics and particularly oxamides as 8,9-EET analogs as bioisosteres of the corresponding epoxide in a therapeutic strategy against sorafenib-induced glomerular nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, N-0316 Oslo, Norway.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA 95616, USA.
ORCID-Profile: Abhishek Mishra, Christophe Morisseau, Bruce D Hammock, John D Imig, Anders Vik
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- NIEHS Superfund Research Program
- NIH-NIEHS (RIVER Award)
- Counter Act Program
- Harrington Brain Health Medicines Scholar Award for Alzheimer’s Disease, Juvenile Diabetes Research Foundation (JDRF)
Zitieren
APA
de Bourg, M., Mishra, A., Mohammad, R. S., Morisseau, C., Hammock, B. D., Imig, J. D., & Vik, A. (2025). Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules, 30(7), 1445. https://doi.org/10.3390/molecules30071445
Vancouver
de Bourg M, Mishra A, Mohammad RS, Morisseau C, Hammock BD, Imig JD, et al. Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules. 2025;30(7):1445. doi:10.3390/molecules30071445
BibTeX
@article{deBourg2025,
author = {de Bourg, Marcus and Mishra, Abhishek and Mohammad, Rawand S and Morisseau, Christophe and Hammock, Bruce D and Imig, John D and Vik, Anders},
title = {Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death},
journal = {Molecules},
year = {2025},
volume = {30},
number = {7},
pages = {1445},
doi = {10.3390/molecules30071445}
}
EUVIMED